Douglas J. Warner
CIK: 0001941311
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TYRA
Tyra Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Warner Douglas J
Warner Douglas J (SEC CIK 0001941311) files insider reports with the SEC as Chief Medical Officer of Tyra Biosciences, Inc. (TYRA).
Signal8 holds 4 ownership filings by Warner Douglas J (1 Form 3, 3 Form 4), filed between Sep 10, 2024 and May 7, 2026. Those filings report 3 transactions, from Sep 9, 2024 to May 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Warner Douglas J's filings is in CARLSBAD, CA.
Recent filings by Warner Douglas J
Other insiders filing for Tyra Biosciences, Inc. (TYRA)
- Harris Todd, President and CEO
- Rueb Yuliya, Vice President, Finance (PAO)
- Fuhrman Alan, Chief Financial Officer
- RA CAPITAL MANAGEMENT, L.P., Director
- Verjee Rehan, Director
- Moran Susan, Director